Literature DB >> 23052903

Recurrent deep vein thrombosis and pulmonary embolism in a patient with Klinefelter's syndrome.

J-W Chung1, J-B Lee, B-H Kim, S-P Hong, J-Y Son, Y-S Lee, J-H Kim, M-J Seong.   

Abstract

Klinefelter's syndrome, which is characterized by small testes, gynecomastia, hypogonadism, and infertility, is the most common cause of primary testicular failure, and commonly has an XXY karyotype. Deep vein thrombosis and thomboembolic events are a rare occurrence in these patients. Although the exact mechanism is not completely understood, it is thought that increased thromboembolic risk in hypogonadic men can be explained by hypofibrinolysis resulting from androgen deficiency. We present the case of a 48-year-old man with Klinefelter's syndrome who experienced recurrent episodes of deep venous thrombosis and pulmonary embolism while undergoing therapeutic anticoagulation. Our report discusses this association and management of the prothrombotic state in patients with Klinefelter's syndrome.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23052903     DOI: 10.1007/s00059-012-3690-1

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  9 in total

1.  Recurrent deep vein thrombosis and pulmonary embolism in a young man with Klinefelter's syndrome and heterozygous mutation of MTHFR-677C>T and 1298A>C.

Authors:  Joel R Angel; Stacey Parker; Ryan E Sells; Ehab Atallah
Journal:  Blood Coagul Fibrinolysis       Date:  2010-06       Impact factor: 1.276

2.  Mortality in patients with Klinefelter syndrome in Britain: a cohort study.

Authors:  Anthony J Swerdlow; Craig D Higgins; Minouk J Schoemaker; Alan F Wright; Patricia A Jacobs
Journal:  J Clin Endocrinol Metab       Date:  2005-10-04       Impact factor: 5.958

3.  Thrombophilia in a man with long-standing hypogonadism.

Authors:  L R Ranganath; L Jones; A G Lim; S R Gould; P F Goddard
Journal:  Postgrad Med J       Date:  1997-11       Impact factor: 2.401

Review 4.  Effect of oral contraceptives on haemostasis variables.

Authors:  C Kluft; M Lansink
Journal:  Thromb Haemost       Date:  1997-07       Impact factor: 5.249

Review 5.  Oral contraceptives, hormone replacement therapy and thrombosis.

Authors:  F R Rosendaal; F M Helmerhorst; J P Vandenbroucke
Journal:  Thromb Haemost       Date:  2001-07       Impact factor: 5.249

Review 6.  Leg ulcers in Klinefelter's syndrome--further evidence for an involvement of plasminogen activator inhibitor-1.

Authors:  T M Zollner; J C Veraart; M Wolter; S Hesse; B Villemur; A Wenke; R J Werner; W H Boehncke; S S Jost; I Scharrer; R Kaufmann
Journal:  Br J Dermatol       Date:  1997-03       Impact factor: 9.302

7.  Antiphospholipid syndrome in a 21-year-old with Klinefelter syndrome.

Authors:  George R Mount; Jonathan D Roebuck
Journal:  J Clin Rheumatol       Date:  2009-02       Impact factor: 3.517

8.  Venous thromboembolic disease in Klinefelter's syndrome.

Authors:  W A Campbell; W H Price
Journal:  Clin Genet       Date:  1981-04       Impact factor: 4.438

Review 9.  Klinefelter's syndrome.

Authors:  Fabio Lanfranco; Axel Kamischke; Michael Zitzmann; Eberhard Nieschlag
Journal:  Lancet       Date:  2004 Jul 17-23       Impact factor: 79.321

  9 in total
  1 in total

1.  Genetic risk factors for venous thromboembolism among infertile men with Klinefelter syndrome.

Authors:  Tarek M Hussein; Dalia Abd Elmoaty Elneily; Fatma Mohamed Abdelfattah Elsayed; Lama M El-Attar
Journal:  J Clin Transl Endocrinol       Date:  2020-05-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.